Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 12, 2026, 8:45 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1993–2016 of 8,697 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Longitudinal Studies Clear all

Conditions: Cataract, Astigmatism
Interventions: Toric Accommodating Lens, Accommodating Lens; Device
Lead sponsor: Bausch & Lomb Incorporated; Industry
Eligibility: 18 Years and older
Enrollment: 229 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 1
States / cities: Bridgewater, New Jersey

Conditions: Movement Disorders, Parkinson's Disease
Interventions: Not listed
Lead sponsor: National Institute of Neurological Disorders and Stroke (NINDS); NIH
Eligibility: 18 Years to 90 Years
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Asthma, Vitamin D Deficiency
Interventions: Vitamin D2 + vitamin D3, Vitamin D3; Drug
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 8 Years to 17 Years
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Surgical Site Infection, Skin Cancer, Wound Healing
Interventions: Cyanoacrylate Skin Adhesive, Fast Gut Running Epidermal Suture Closure, Vicryl Rapide Running Epidermal Suture Closure, Prolene Running Epidermal Suture Closure; Device · Procedure
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years and older
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 3
States / cities: Minneapolis, Minnesota

Conditions: Full-thickness Skin Defects, Degloving Injuries, Crush Injuries, Laceration of Skin, Surgical Wound, Skin Cancer, Cellulitis, Infection, Necrotizing Fasciitis, Gun Shot Wound
Interventions: Control Intervention (Conventional Autograft), Investigational Intervention (RECELL + more widely meshed autograft); Procedure · Device
Lead sponsor: Avita Medical; Industry
Eligibility: 5 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 18
States / cities: Phoenix, Arizona • Tucson, Arizona • Orange, California + 14 more

Conditions: Graft Versus Host Disease
Interventions: medical chart review, quality-of-life assessment; Other
Lead sponsor: Vanderbilt-Ingram Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 19 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2018
U.S. locations: 4
States / cities: Scottsdale, Arizona • Rochester, Minnesota • Cleveland, Ohio + 1 more

Conditions: Pain Control, Ureteral Reimplantation, Pediatrics, Intrathecal Morphine
Interventions: Intrathecal Morphine, Quadratus lumborum block; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 12 Months to 11 Years
Enrollment: 14 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2024
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Bronchopulmonary Dysplasia
Interventions: MagniXene, hyperpolarized 129Xe MRI; Combination Product
Lead sponsor: Xemed LLC; Industry
Eligibility: Up to 1 Year
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2031
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Capsular Contracture Associated With Breast Implant, Capsular Contracture Grade III, Capsular Contracture Grade IV
Interventions: GalaFLEX LITE™ Scaffold, Standard surgery; Device · Other
Lead sponsor: C. R. Bard; Industry
Eligibility: 22 Years to 70 Years · Female only
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2029
U.S. locations: 37
States / cities: Scottsdale, Arizona • Beverly Hills, California • Huntington Beach, California + 29 more

Conditions: REM Behavior Disorder, Parkinson Disease
Interventions: Not listed
Lead sponsor: CND Life Sciences; Other
Eligibility: 50 Years to 85 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 18
States / cities: Scottsdale, Arizona • Irvine, California • Los Angeles, California + 14 more

Conditions: Restenosis
Interventions: Spectranetics Laser with adjunct PTA and Gore VIABAHN Endoprosthesis with Heparin Bioactive Surface; Device
Lead sponsor: VIVA Physicians; Other
Eligibility: 18 Years to 89 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: X-linked Myotubular Myopathy
Interventions: Not listed
Lead sponsor: Cure CMD; Other
Eligibility: Male only
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2015
U.S. locations: 1
States / cities: Torrance, California

Conditions: Mucopolysaccharidoses
Interventions: Not listed
Lead sponsor: Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center; Other
Eligibility: 5 Years to 35 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2019
U.S. locations: 3
States / cities: Oakland, California • Torrance, California • Minneapolis, Minnesota

Conditions: Swallowing Disorders, Achalasia, Outlet Obstruction, Gastric, Diffuse Esophageal Spasm
Interventions: Not listed
Lead sponsor: Baylor College of Medicine; Other
Eligibility: 18 Years to 64 Years
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Houston, Texas

Conditions: DNA Damage, DNA Strand Breaks, Sperm DNA Fragmentation
Interventions: sperm separation device; Device
Lead sponsor: Richard Kordus, PhD, HCLD (ABB); Other
Eligibility: 18 Years to 34 Years
Enrollment: 50 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Major Depressive Disorder
Interventions: NeuroStar TMS; Device
Lead sponsor: Neuronetics; Other
Eligibility: 18 Years to 70 Years
Enrollment: 67 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 6
States / cities: Chicago, Illinois • Baltimore, Maryland • Lincoln, Nebraska + 3 more

Conditions: Acute Pain
Interventions: Morphine, Placebo; Drug
Lead sponsor: Stony Brook University; Other
Eligibility: 18 Years to 80 Years
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Stony Brook, New York

Conditions: Bacterial Vaginosis
Interventions: SYM-1219, Placebo; Drug
Lead sponsor: Symbiomix Therapeutics; Industry
Eligibility: 12 Years and older · Female only
Enrollment: 189 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 21
States / cities: Birmingham, Alabama • Jonesboro, Arkansas • San Diego, California + 17 more

Conditions: To Validate the Clinical Performance of AI/ML Technologies in First-trimester Pregnant Participants, First Trimester Pregnancy
Interventions: Images and cines captured through the capture card (ICC); Device
Lead sponsor: Origin Medical Systems, Inc.; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 551 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 15
States / cities: Apple Valley, California • Indio, California • Murrieta, California + 12 more

Conditions: Occupational Exposure
Interventions: Qualitative Fit Testing; Other
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Hallux Valgus
Interventions: (EWB) Early Weight Bearing (2 Weeks Post-op); Other
Lead sponsor: Orthopaedic Associates of Michigan, PC; Other
Eligibility: 18 Years and older
Enrollment: 131 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2017
U.S. locations: 1
States / cities: Grand Rapids, Michigan

Conditions: Anesthesia Induction
Interventions: Dark with star projector, Preoperative midazolam, Parental Presence; Other · Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 2 Years to 6 Years
Enrollment: 240 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Human Microbiome
Interventions: Pomella, Placebo; Dietary Supplement · Other
Lead sponsor: Integrative Skin Science and Research; Industry
Eligibility: 25 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Sacramento, California

Conditions: Systemic Lupus Erythematosus
Interventions: Anifrolumab; Drug
Lead sponsor: AstraZeneca; Industry
Eligibility: Female only
Enrollment: 442 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2031
U.S. locations: 1
States / cities: Wilmington, North Carolina

Search by objective public record fields.

Toric Intraocular Lens Following Cataract Surgery

A Study of Movement Disorders Using the QMAT At-Home Testing Device

Vitamin D in Pediatric Asthma: a Randomized Controlled Open-label Pilot Trial

Cyanoacrylate Skin Adhesive After Mohs Surgery or Wide Local Excision

RECELL® System Combined With Meshed Autograft for Reduction of Donor Skin Harvesting in Soft Tissue Reconstruction

Prospective Outcomes of Second-Line Therapy in Acute Graft-Versus-Host Study Including ECP (POSTAGE)

ITM vs QL for Pediatric Open Lower Abdominal Procedures

129Xe MRI in Pediatric Population With BPD

Study of GalaFLEX LITE™ Scaffold in Treatment of Capsular Contracture After Breast Implant Augmentation

Quantification of Phosphorylated Alpha-synuclein in Cutaneous Biopsies as a Prospective Biomarker in Parkinson's Disease

Study to Evaluate the Safety and Performance of Spectranetics Laser w/Adjunct PTA and Gore Viabahn Endoprosthesis for Treatment of SFA Instent Restenosis

Myotubular Myopathy Event Study

Longitudinal Study of Bone Disease in Children with Mucopolysaccharidoses (MPS) I, II, and VI

Transoral Incisionless Fundoplication in Post-POEM GERD

Comparison of Two Different Sperm Processing Methods and Their Effects on Sperm DNA Fragmentation and Embryo Development

Maintenance NeuroStar Transcranial Magnetic Stimulation (TMS) in Patients With Major Depressive Disorder

Study to Examine Pain Relief With Supplemental Intrathecal Morphine in TKA Patients

A Phase 3 Study of SYM-1219 Treatment of Women and Post-Menarchal Adolescent Girls With Bacterial Vaginosis

Clinical Performance Evaluation of the Artificial Intelligence (AI)/ Machine Learning (ML) Technologies Utilized by the Origin Medical EXAM ASSISTANT

Effectiveness of Respiratory Protection During Simulated Resuscitation: a Prospective Cohort Study

Early Weight Bearing Tarsometatarsal Fusion Study

Induction in the Dark

Oral Pomegranate Extract on the Microbiome and Skin Biophysical Properties

Prospective Registry Investigating Maternal and Infant Outcomes in Anifrolumab Users